` NST (Nestmedic SA) vs WIG20 Comparison - Alpha Spread

N
NST
vs
W
WIG20

Over the past 12 months, NST has underperformed WIG20, delivering a return of +13% compared to the WIG20's +29% growth.

Stocks Performance
NST vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NST vs WIG20

Loading
NST
WIG20
Difference
www.alphaspread.com

Performance By Year
NST vs WIG20

Loading
NST
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Nestmedic SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nestmedic SA
Glance View

Market Cap
27.2m PLN
Industry
Health Care

Nestmedic SA is engaged in the production of medical devices and software. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2017-06-12. The firm focuses on the development and production of a telemedicine cardiotocography (CTG) device for fetal health monitoring, named Pregnabit. The Pregnabit solution comprises the display device; fetal heart rate (FHR) probe; wrist heart rate monitor, which measures mother’s pulse; tocodynamometer (toco) probe, which measures contractions of the uterus, as well as fetal movement marker. Pregnabit enables pregnant women to take CTG tests at home, without specialist's assistance. The results are sent wirelessly to Medical Telemonitoring Center (MTC) where medical consultant analyzes data and provides medical opinion.

NST Intrinsic Value
0.05 PLN
Overvaluation 92%
Intrinsic Value
Price
N
Back to Top